Effect of novel antimalarial ZY-19489 on Plasmodium falciparum viability in a volunteer infection study

Affiliations

• ¹ Kirby Institute, University of New South Wales, Sydney, NSW, Australia.
• ² QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.
• ³ Zydus Research Centre, Ahmedabad, India.
• ⁴ Medicines for Malaria Venture, Geneva, Switzerland.
• ⁵ QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia; The Peter Doherty Institute for Infection and Immunity, The University of Melbourne and the Royal Melbourne Hospital, Melbourne, VIC, Australia.
• ⁶ QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia; Instituto de Medicina Molecular Joao Lobo Antunes, Lisbon 1649-028, Portugal. Electronic address: mariarebelo@medicina.ulisboa.pt.